Is Amgen Inc. overvalued?

Amgen Inc. (AMGN) looks overvalued — trading about 31% above its fair value.

Overvalued

Price

$465.67

Fair value

$321.03

Current P/E

32.7

Normal P/E

22.6

Market cap

$251.89B

Dividend yield

2.1%

Return on equity

85.6%

Sector

Healthcare

Fair value compares AMGN's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 15 Nov 2026.

Related stocks